Custom service
Phage Display Peptide Library
Screen phage-display peptide libraries for target binding
Phage Display Peptide Library supports programmes that screen phage-display peptide libraries for target binding. In a typical engagement we plan the 7-mer, 12-mer and cyclic display formats route first, confirm compatibility with biopanning with counterselection, and release enriched hits with sequence frequency data on a 6–10 weeks schedule.
Chemistry is chosen for the molecule, not from a menu. Where the payload tolerates it we keep 7-mer, 12-mer and cyclic display formats as the primary option and hold biopanning with counterselection in reserve, so that scale-up never depends on an unproven step.
Discovery against purified targets
Motif discovery for targeting peptides
Targets that coat phage non-specifically
Targets with no assayable readout and no purified protein available
Screening programmes close with a data package: primary screen statistics, confirmation data for each hit, counterscreen results and resynthesized material. Library lots ship with composition QC — representation and identity checks by LC-MS or NGS as the format requires.
Service Highlights
- 7-mer, 12-mer and cyclic display formats as the default route, with biopanning with counterselection held as a proven fallback
- NGS hit deconvolution worked into the design where the application requires it
- Every reported hit is confirmed by independent resynthesis and re-testing before it reaches you
- Analytical confirmation of every intermediate before the final release
- Library integrity (composition, representation) is measured, not assumed, before screening begins
- Enriched hits with sequence frequency data delivered with a complete conjugation or synthesis certificate
How the work runs
Library design
Diversity, degeneracy and deconvolution strategy for Phage Display Peptide Library are fixed in a design document.
Library synthesis or construction
The library is built with 7-mer, 12-mer and cyclic display formats and its composition is QC'd before screening.
Primary screening
Screening runs with biopanning with counterselection, with controls and statistics defined in advance.
Hit deconvolution
Hits are identified and ranked; counterscreens remove non-specific and promiscuous binders.
Hit confirmation
Every hit is resynthesized and re-tested; only reproducible hits advance.
Hit delivery
Confirmed hits and Enriched hits with sequence frequency data are delivered with the full screening data package.
Specifications & timeline
- Turnaround
- 6–10 weeks
- Typical scale
- 10^2 – 10^9 members by format
- Chemistry options
- 7-mer, 12-mer and cyclic display formats; biopanning with counterselection; NGS hit deconvolution
- Deliverable
- Enriched hits with sequence frequency data
- QC package
- Library composition QC, screening raw data, hit confirmation package
- Shipping
- Ambient (plates, beads) or dry ice (display libraries)
Related Products
- Recombinant ProteinsGrowth factors, cytokines and antigens produced across E. coli, yeast, insect and mammalian hosts — over 10,000 items on the shelf and ready to move.
- Native ProteinsIsolated directly from natural sources, preserving native post-translational modifications and conformational epitopes that recombinant systems can miss.
- Monoclonal AntibodiesRecombinant and hybridoma clones characterised for Western blot, IHC, immunofluorescence, ELISA and flow cytometry — application data included.
Next step
Tell us the target, we will tell you what is feasible
Send the sequence, assay format and sensitivity you need. You will get a technical assessment — recommended platform, timeline and the risks worth knowing before you commit budget.